Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
55.25
-1.01 (-1.80%)
At close: Mar 24, 2026, 4:00 PM EDT
55.42
+0.17 (0.31%)
After-hours: Mar 24, 2026, 4:10 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $369.21 million as of March 24, 2026. Its market cap has increased by 112.88% in one year.
Market Cap
369.21M
Enterprise Value
225.64M
1-Year Change
112.88%
Ranking
Category
Stock Price
$55.25
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $369.21M, an increase of 33.70%. That is a compound annual growth rate of 4.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 375.96M | -13.84% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 383.95M |
| Nautilus Biotechnology | 382.70M |
| PureTech Health | 381.76M |
| Benitec Biopharma | 377.21M |
| Anavex Life Sciences | 376.25M |
| Niagen Bioscience | 373.18M |
| Autolus Therapeutics | 364.62M |
| Candel Therapeutics | 364.04M |